Eman E. Hawy

Eman Hawy practices at Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD in Loma Linda, California.

Eman Hawy's NPI, 1871911917, was assigned on April 5, 2014. Eman Hawy graduated from Ain Shams University Faculty of Medicine in 2012. Eman Hawy holds California license 138906.

Eman Hawy's primary practice is Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD, at 11370 Anderson St, Loma Linda, CA 92354.

Eman Hawy's primary practice is Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD in Loma Linda, California. Eman Hawy is also affiliated with Loma Linda University Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Eman Hawy to 1 more hospital, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account. Eman Hawy's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Eman Hawy practices, 5 sites in all. Vendor and product names are available with a free account.

Neuro-ophthalmology is Eman Hawy's primary specialty in the NPI Registry, under taxonomy code 207WX0109X. Eman Hawy is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Eman Hawy's licenses on file in 3 states: California, Georgia and Vermont.

Dmand AI lists glaucoma, shingles and vision problems among the conditions Eman Hawy treats.

CMS data shows 541 Medicare services from Eman Hawy across 8 procedure codes in 2024, for 187 Medicare patients. Medicare paid $37,860 for them. Every service was in an office.

CMS counts 187 Medicare patients who saw Eman Hawy in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 37% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Eman Hawy's median patient age at 63, with 67% women.

In 2024, Eman Hawy wrote 478 Medicare Part D claims for 149 patients. 72% of them were for generic drugs. CMS names the drug for 382 of them, across 13 drugs with 11 or more claims each, at $23,425 in total drug cost. In 2023, CMS named 332 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Eman Hawy for performance year 2024, reported as part of a group. Eman Hawy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Eman Hawy as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Eman Hawy, published from 2021 to 2024. 2021 was the busiest year, with 2. Eman Hawy's most frequent co-authors are Konstantin V. Astafurov, MD, PhD, John Danias, MD, PhD and Michael Dattilo, MD, PhD.

CMS Open Payments shows 21 general payments to Eman Hawy from 6 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 93% of the total. Horizon Pharma plc paid the most, $171.

Dmand AI lists 1 award for Eman Hawy, most recently Healing Hands in 2022.

Eman Hawy graduated from Ain Shams University Faculty of Medicine in 2012. Eman Hawy is a member of AAN, AAO and North American Neuro-Ophthalmology Society.

Eman Hawy is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.